CTT Pharmaceutical Holdings, Inc.
CTTH
Rank in Stocks
#31305
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug... CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The companyโs technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
Share Price
$0.0559
Last synced: 2026-11-10
Market Cap
$3.34M
Change (1 day)
0.18%
Change (1 year)
36.01%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade CTT Pharmaceutical Holdings, Inc. (CTTH)
Category
Healthcare
EPS for CTT Pharmaceutical Holdings, Inc. (CTTH)
EPS as of June 2026 TTM: $0.00
According to CTT Pharmaceutical Holdings, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for CTT Pharmaceutical Holdings, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -30.77% |
| 2025 | 0.00 | -30.77% |
| 2024 | 0.00 | 387.50% |
| 2023 | 0.00 | -27.27% |
| 2022 | 0.00 | -59.26% |
| 2021 | 0.00 | -78.05% |
| 2020 | $-0.01 | 0.00% |
| 2019 | $-0.01 | -66.49% |
| 2018 | $-0.04 | 2.80% |
| 2017 | $-0.04 | 32.71% |
| 2016 | $-0.03 | -61.18% |
| 2015 | $-0.07 | -793.00% |
| 2014 | $0.01 | -91.67% |
| 2013 | $0.12 | -111.21% |
| 2012 | $-1.07 | -125.48% |
| 2011 | $4.20 | -423.08% |
| 2010 | $-1.30 | -35.00% |
| 2009 | $-2.00 | -11.89% |
| 2008 | $-2.27 | -47.58% |
| 2007 | $-4.33 | 100.46% |
| 2006 | $-2.16 | -34.74% |
| 2005 | $-3.31 | 141.61% |
| 2004 | $-1.37 | -49.63% |
| 2003 | $-2.72 | 149.54% |
| 2002 | $-1.09 | -76.41% |
| 2001 | $-4.62 | -94.71% |
| 2000 | $-87.38 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | -130,100.00% |
US
|
|
| $1.93 | -148,623.08% |
SE
|
|
| $6.91 | -531,946.15% |
FR
|
|
| $0.02 | -1,600.00% |
HK
|
|
| $2.71 | -208,546.15% |
IT
|
Questions about CTT Pharmaceutical Holdings, Inc.'s earnings per share (EPS)
What is CTT Pharmaceutical Holdings, Inc.'s earnings per share (EPS)?
CTT Pharmaceutical Holdings, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.
What was CTT Pharmaceutical Holdings, Inc.'s earnings per share (EPS) in 2025?
In 2025, CTT Pharmaceutical Holdings, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has CTT Pharmaceutical Holdings, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, CTT Pharmaceutical Holdings, Inc.'s earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2020 ($-0.01).
How does CTT Pharmaceutical Holdings, Inc.'s earnings per share (EPS) compare with similar companies?
CTT Pharmaceutical Holdings, Inc.'s earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.